Examination Practice Ofantibody-Related Patent Applications In China

Antibody-related drugs can be used to treat major diseases such as malignant tumors, immune diseases, infectious or allergic diseases, blood or extracellular fluid diseases, and thus have attracted attention from across the world. Being the most active component of the biopharmaceutical industry, antibody-related drugs have become a diamond in the rough for future biopharmaceutical development.

 With the continuous deepening of intellectual property strategies of encouraging innovation and the continuous strengthening of intellectual property protection and law enforcement in China, China has been recognized by life science companies as an extremely important biopharmaceutical market with significant growth potential. Patent protection is of great importance to the development of the pharmaceutical industry. What are the most frequently encountered challenges for biomedical companies in the process of seeking patent protections for antibody-related inventions? This